ReWalk Robotics Hopes to Raise $50M in IPO
From Boston Herald:
A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)
Comments (0)
This post does not have any comments. Be the first to leave a comment below.
Featured Product
Revolutionize Your PCB Prototyping Assembled in the USA: Fast Turnaround, High Quality
At MacroFab, we understand the challenges engineers face when searching for the perfect partner to bring their visions to life. Traditional overseas prototype factories may offer low-cost solutions but often have hidden compromises. Say goodbye to subpar quality, communication barriers, and frustrating delays - choose MacroFab for a stress-free, reliable, and professional prototyping experience.
